Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Diabetes: The $54 billion battleground
CNBC
Friday, June 13, 2014 - 12:26pm
tags:
diabetes, Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca
What Is Next For The Hepatitis C Space?
Seeking Alpha
Friday, June 13, 2014 - 11:05am
tags:
hepatitis C, Conatus Pharmaceuticals, Gilead Sciences, Merck, Idenix
Apple's Venture Into Mobile Medical Applications: A Game Changer?
Seeking Alpha
Friday, June 13, 2014 - 11:03am
tags:
Apple, mHealth, Google
Galena Promoting Experimental Breast Cancer Drug With Faux News Articles Again
TheStreet.com
Friday, June 13, 2014 - 11:00am
tags:
Galena Biopharma, breast cancer, SEC, NeuVax
What Will Happen When Biotech Drugs Go Generic?
Forbes
Friday, June 13, 2014 - 10:58am
tags:
biotech, generics, Amgen, Roche, Biogen Idec, Eli Lilly, Bristol-Myers Squibb, Sanofi, Novartis, Sandoz, Omnitrope, Genotropin
Drug-linked payouts - complex fix for Pfizer's next Astra bid?
Yahoo/Reuters
Friday, June 13, 2014 - 10:55am
tags:
Pfizer, AstraZeneca, M&A
Spooked by probes, pharma executives ask: should I leave China?
Yahoo/Reuters
Friday, June 13, 2014 - 10:48am
tags:
China
Valeant Headlines Puncture Strategy as Stock Drops: Opening Line
Bloomberg
Friday, June 13, 2014 - 9:44am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Allergan-Valeant Deal Gets Pershing Poison Pill Warning
Bloomberg
Friday, June 13, 2014 - 9:43am
tags:
Allergan, Valeant Pharmaceuticals, poison pill, M&A
Johnson & Johnson: A New Marketing Strategy Could Drive Growth
Seeking Alpha
Friday, June 13, 2014 - 9:30am
tags:
JNJ, R&D
Genomic Health's Oncotype DX Redefines Breast Cancer Therapy
Yahoo/Zacks.com
Friday, June 13, 2014 - 9:25am
tags:
Oncotype DX, breast cancer, Genomic Health, diagnostics
Bayer Looking to Expand Eylea's Label
Yahoo/Zacks.com
Friday, June 13, 2014 - 9:23am
tags:
Bayer, Eylea, BRVO
FDA approves Medtronic's CoreValve for larger group of patients with diseased heart valve
Yahoo/AP
Friday, June 13, 2014 - 9:23am
tags:
FDA, CoreValve, Medtronic, devices
Roche's Purchase Of Genia A Long-Term Move
Seeking Alpha
Friday, June 13, 2014 - 9:20am
tags:
Roche, Genia Technologies, M&A
Merck open to more biotech deals - research chief
Yahoo/Reuters
Friday, June 13, 2014 - 9:18am
tags:
Roger Perlmutter, R&D, M&A, Merck, biotech
FDA panel advises against large opioid-constipation drug safety trials
Yahoo/Reuters
Thursday, June 12, 2014 - 2:22pm
tags:
FDA, advisory panels, opioid-induced constipation
Preschoolers to Get ADHD Drug Vyvanse in Shire Study
Bloomberg
Thursday, June 12, 2014 - 2:21pm
tags:
ADHD, Vyvanse, Shire
Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong
Forbes
Thursday, June 12, 2014 - 2:18pm
tags:
Valeant Pharmaceuticals, R&D
As the Dow Declines, Why Are Pfizer and Merck Rising?
Motley Fool
Thursday, June 12, 2014 - 2:16pm
tags:
Pfizer, Merck
Inovio shares dive on cervical cancer vax speculation
Fierce Vaccines
Thursday, June 12, 2014 - 11:19am
tags:
Inovio, cervical cancer, vaccines, VGX-3100

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.